Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • World View
  • Published:

What cancer survivors can teach cancer researchers

Cancer survivors have been increasingly advocating for research into the long-term effects of their treatments. Some researchers working on cancer survivorship issues engage survivors productively with their teams, but many do not, negatively impacting innovation in this field. Cancer survivors must be included in every stage of this research process.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. The American Cancer Society medical and editorial content team. Key Statistics for Childhood Cancers. ACS https://www.cancer.org/cancer/cancer-in-children/key-statistics.html (2022).

  2. Hudson, M. M. et al. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA 309, 2371–2381 (2013).

    Article  CAS  Google Scholar 

  3. Hill, F. G. H. et al. Successful treatment without cranial radiotherapy of children receiving intensified chemotherapy for acute lymphoblastic leukaemia: results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI (ISRC TN 16757172). Br. J. Haematol. 124, 33–46 (2004).

    Article  CAS  Google Scholar 

  4. van der Plas, E. et al. Neurocognitive late effects of chemotherapy in survivors of acute lymphoblastic leukemia: focus on methotrexate. J. Can. Acad. Child Adolesc. Psychiatry. 24, 25–32 (2015).

    PubMed  PubMed Central  Google Scholar 

  5. Gibson, E. M. et al. Methotrexate chemotherapy induces persistent tri-glial dysregulation that underlies chemotherapy-related cognitive impairment. Cell 176, 43–55 (2019).

    Article  CAS  Google Scholar 

  6. Hunter, B. D. & Jacobson, C. A. CAR T-cell associated neurotoxicity: mechanisms, clinicopathologic correlates, and future directions. J. Natl Cancer Inst. 111, 646–654 (2019).

    Article  Google Scholar 

  7. Forster, V. J. et al. Drug interactions may be important risk factors for methotrexate neurotoxicity, particularly in pediatric leukemia patients. Cancer Chemother Pharmacol. 78, 1093–1096 (2016).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Victoria J. Forster.

Ethics declarations

Competing interests

The author declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Forster, V.J. What cancer survivors can teach cancer researchers. Nat Rev Cancer 22, 431–432 (2022). https://doi.org/10.1038/s41568-022-00468-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41568-022-00468-z

This article is cited by

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer